# Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction

> **NCT00387621** · PHASE1,PHASE2 · COMPLETED · sponsor: **Horng Chen** · enrollment: 58 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Nesiritide
- **DRUG:** Placebo
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00387621
- **Lead sponsor:** Horng Chen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-08
- **Final completion:** 2009-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2012-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387621, "Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00387621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*